I think the key take away from this announcement are:
- Ellume uses AnteoBind, then "AnteoBind is a key element of AnteoTech’s own COVID-19 Antigen Rapid Test" - Therefore, AnteoBind is key to Ellume and Ellume is successful, because of AnteoBind
- Ellume received EUA from FDA, which paves way for our test "Ellume’s announcement is a welcome event that is a demonstration of AnteoTech’s importance in helping deliver key diagnostic products to global markets."
- There's no immediate increase in orders for AnteoBind YET, but that's because Ellume hasn't even started building their US facility yet! But it will come, soon. "Forecast volume requirements of AnteoBind for periods beyond this date have not yet been received from Ellume."
TGA, CE, FDA approvals next, with left field distribution/manufacturing contracts IMO.
I think the key take away from this announcement are:Ellume uses...
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.90M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $23.42K | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1142321 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 339684 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| ADO (ASX) Chart |